On August 24, 2001 a proposed class action was commenced against Bayer Inc. ("Bayer") arising out of that company's marketing of the cholesterol-lowering drug known alternatively as Baycol, Cervastatin or Lipobay ("Baycol").

Counsel for the proposed class action are Branch MacMaster, Hanson Wirsig Matheos and Joseph M. Prodor.

Click here for more information on the status of the class action and the proposed settlement.